CH679210A5 - - Google Patents

Download PDF

Info

Publication number
CH679210A5
CH679210A5 CH3835/89A CH383589A CH679210A5 CH 679210 A5 CH679210 A5 CH 679210A5 CH 3835/89 A CH3835/89 A CH 3835/89A CH 383589 A CH383589 A CH 383589A CH 679210 A5 CH679210 A5 CH 679210A5
Authority
CH
Switzerland
Prior art keywords
percent
component
composition
eye
amount
Prior art date
Application number
CH3835/89A
Other languages
German (de)
English (en)
Inventor
Ronald Edward Peeples
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH679210A5 publication Critical patent/CH679210A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CH3835/89A 1988-10-26 1989-10-24 CH679210A5 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
CH679210A5 true CH679210A5 (pt) 1992-01-15

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3835/89A CH679210A5 (pt) 1988-10-26 1989-10-24

Country Status (24)

Country Link
JP (1) JPH02164830A (pt)
KR (1) KR900005973A (pt)
AU (1) AU626928B2 (pt)
BE (1) BE1003578A4 (pt)
CA (1) CA2001502A1 (pt)
CH (1) CH679210A5 (pt)
DE (1) DE3935517A1 (pt)
DK (1) DK531289A (pt)
ES (1) ES2020032A6 (pt)
FI (1) FI895064A0 (pt)
FR (1) FR2638089A1 (pt)
GB (1) GB2224205B (pt)
GR (1) GR1000611B (pt)
HU (1) HU203046B (pt)
IL (1) IL92120A (pt)
IT (1) IT1237824B (pt)
LU (1) LU87613A1 (pt)
MY (1) MY106271A (pt)
NL (1) NL8902657A (pt)
NO (1) NO894266L (pt)
NZ (1) NZ231131A (pt)
PT (1) PT92120B (pt)
SE (1) SE8903583L (pt)
ZA (1) ZA898140B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ATE147619T1 (de) * 1992-05-13 1997-02-15 Sandoz Ag Opthalmische zusammensetzungen enthaltend ein cyclosporin
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
TR199901686T2 (xx) 1997-01-30 1999-09-21 Norvartis Ag Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller.
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) * 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
ES2402321T3 (es) * 2007-11-05 2013-04-30 Bausch & Lomb Incorporated Materiales inmiscibles en agua como vehículos para el suministro de fármacos
US8496976B2 (en) * 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
HU203046B (en) 1991-05-28
MY106271A (en) 1995-04-29
FR2638089A1 (fr) 1990-04-27
DK531289A (da) 1990-04-27
IT1237824B (it) 1993-06-18
FI895064A0 (fi) 1989-10-25
NZ231131A (en) 1992-06-25
BE1003578A4 (fr) 1992-04-28
NO894266L (no) 1990-04-27
KR900005973A (ko) 1990-05-07
DK531289D0 (da) 1989-10-25
DE3935517A1 (de) 1990-05-03
HUT52394A (en) 1990-07-28
AU4371589A (en) 1990-05-03
PT92120A (pt) 1990-04-30
GR1000611B (el) 1992-08-31
LU87613A1 (fr) 1991-05-07
GB2224205B (en) 1992-04-15
CA2001502A1 (en) 1990-04-26
NL8902657A (nl) 1990-05-16
HU895444D0 (en) 1990-01-28
SE8903583D0 (sv) 1989-10-26
GR890100690A (en) 1990-11-29
AU626928B2 (en) 1992-08-13
SE8903583L (sv) 1990-04-27
IL92120A0 (en) 1990-07-12
NO894266D0 (no) 1989-10-26
IT8948485A0 (it) 1989-10-26
GB8924040D0 (en) 1989-12-13
ZA898140B (en) 1991-06-26
IL92120A (en) 1994-02-27
GB2224205A (en) 1990-05-02
PT92120B (pt) 1995-06-30
ES2020032A6 (es) 1991-07-16
JPH02164830A (ja) 1990-06-25

Similar Documents

Publication Publication Date Title
CH679210A5 (pt)
EP0616801B1 (de) Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
DE3915617B4 (de) Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation
DE69531389T2 (de) Cyclosporin enthaltende multiple Emulsionen
DE3930928C2 (de) Cyclosporin enthaltende pharmazeutische Formulierungen
DE69926843T2 (de) Aktives vitamin-d3 enthaltende lotionen in form von emulsionen
DE3924207C2 (pt)
DE60210568T2 (de) Coenzym Q10 zur Behandlung von Erkrankungen der Augen
EP0256285A1 (de) Pharmazeutische Formulierung und Verfahren zu deren Herstellung
DE69731072T2 (de) Cyclosporin enthaltende weichkapselpräparate
DE2902863A1 (de) Waessriges gel zur anwendung im bindehautsack
EP0585896B1 (de) Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
DE69921409T2 (de) Cyclosporin enthaltende Zusammensetzungen
DE3330053C2 (pt)
DE3815581A1 (de) Ophthalmologische zusammensetzung
DE3643119A1 (de) Therapeutische zusammensetzung fuer diabetes-komplikationen
DE60005992T2 (de) Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien
EP0618797A1 (de) Bilobalid enthaltende pharmazeutische zubereitungen zur behandlung von spannungs- und angstzuständen
DE60017174T2 (de) Rivastigmine zur behandlung von augenerkrankungen
DE60027878T2 (de) Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb
DE60304458T2 (de) Verwendung eines l-ascorbinsäuresalzes zur herstellung einer pharmazeutischen zusammensetzung für die ophthalmische topische anwendung zur verbesserung des l-ascorbinsäurespiegels im auge
DE2330338A1 (de) Okular-hypotensives mittel
Grehn et al. Thymoxamine: a miotic for intraocular use
Naumann et al. Embryologie, Anatomie und Untersuchungstechnik
DE1617653B1 (de) Indomethacinpraeparat zur externen Anwendung

Legal Events

Date Code Title Description
PL Patent ceased